Isnt It Time You Became Fully Optimized To Live Longer And Stronger
How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
Retrieved from Li, A., Li, X., Zhou, T., et al
Months 3 to 6: Full effects plateau
Both are effective, both are FDA-approved, and both are widely prescribed
Properly storing your medication is not just about following rules